Tessera Therapeutics Receives Grant to Advance In Vivo Gene Writing Approaches Towards a Potential Human Immunodeficiency Virus (HIV) Cure

AI Briefing

• – Tessera Therapeutics receives Gates Foundation grant to advance HIV cure approaches
• – Funding supports development of multiple in vivo gene writing strategies
• – Goal is to enable a scalable cure for HIV